Bessemer Group Inc. Has $1.07 Million Position in DaVita Inc. (NYSE:DVA)

Bessemer Group Inc. reduced its position in shares of DaVita Inc. (NYSE:DVA) by 77.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,017 shares of the company’s stock after selling 23,776 shares during the quarter. Bessemer Group Inc.’s holdings in DaVita were worth $1,073,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in DVA. Moran Wealth Management LLC increased its stake in shares of DaVita by 6.2% in the first quarter. Moran Wealth Management LLC now owns 117,204 shares of the company’s stock worth $17,929,000 after acquiring an additional 6,882 shares during the last quarter. Asset Management One Co. Ltd. increased its stake in shares of DaVita by 3.5% in the first quarter. Asset Management One Co. Ltd. now owns 20,063 shares of the company’s stock worth $3,069,000 after acquiring an additional 682 shares during the last quarter. Heartland Bank & Trust Co acquired a new position in shares of DaVita in the first quarter worth $353,000. Blue Trust Inc. increased its stake in shares of DaVita by 150.9% in the first quarter. Blue Trust Inc. now owns 567 shares of the company’s stock worth $87,000 after acquiring an additional 341 shares during the last quarter. Finally, Precision Wealth Strategies LLC increased its stake in shares of DaVita by 12.2% in the first quarter. Precision Wealth Strategies LLC now owns 2,724 shares of the company’s stock worth $417,000 after acquiring an additional 297 shares during the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Trading Up 0.5%

Shares of NYSE:DVA opened at $142.40 on Tuesday. The stock has a market capitalization of $10.75 billion, a PE ratio of 14.11, a P/E/G ratio of 0.98 and a beta of 1.11. DaVita Inc. has a 1 year low of $131.76 and a 1 year high of $179.60. The firm has a fifty day moving average price of $139.64 and a 200 day moving average price of $149.38. The company has a current ratio of 1.25, a quick ratio of 1.20 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.25. The firm had revenue of $3.22 billion during the quarter, compared to analysts’ expectations of $3.22 billion. DaVita had a net margin of 6.63% and a return on equity of 176.11%. DaVita’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same period in the prior year, the company posted $2.26 earnings per share. Analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on DVA. Truist Financial dropped their price target on shares of DaVita from $170.00 to $164.00 and set a “hold” rating on the stock in a research note on Monday, May 19th. Wall Street Zen raised shares of DaVita from a “hold” rating to a “buy” rating in a research note on Friday, April 25th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $164.50.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.